The trauma INtramuscular Tranexamic Acid Clinical Trial

Phase 1

• Conditions: Traumatic haemorrhage; MedDRA version: 20.0Level: PTClassification code 10053476Term: Traumatic haemorrhageSystem Organ Class: 10022117 - Injury, poisoning and procedural complications; Therapeutic area: Body processes [G] - Physiological processes [G07]

• Registration Number: EUCTR2019-000898-23-GB
• Lead Sponsor: ondon School of Hygiene and Tropical Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-14
• Last Update Posted: 13 October 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

- Adult (appear to be at least 16 years old) trauma patients
- Received 1 gram of intravenous tranexamic acid for the management of haemorrhage
- A second dose of tranexamic acid is clinically indicated
Are the trial subjects under 18? yes
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 5

Exclusion Criteria

none

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified